SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Apollo Medical Holdings, Inc. – ‘8-K’ for 9/26/22

On:  Monday, 9/26/22, at 3:04pm ET   ·   For:  9/26/22   ·   Accession #:  1628280-22-25455   ·   File #:  1-37392

Previous ‘8-K’:  ‘8-K’ on / for 8/4/22   ·   Next:  ‘8-K’ on 10/6/22 for 10/5/22   ·   Latest:  ‘8-K’ on 4/24/24 for 4/23/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/26/22  Apollo Medical Holdings, Inc.     8-K:8,9     9/26/22   11:227K                                   Workiva Inc Wde… FA01/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     41K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     15K 
 6: R1          Document and Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- ameh-20220926_htm                   XML     22K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- ameh-20220926_lab                     XML     68K 
 5: EX-101.PRE  XBRL Presentations -- ameh-20220926_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- ameh-20220926                         XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0001628280-22-025455-xbrl      Zip     21K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  ameh-20220926  
 i 0001083446 i false00010834462022-09-262022-09-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM  i 8-K
 
CURRENT REPORT
 Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  i September 26, 2022
 
 i APOLLO MEDICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified in Charter)
 
 i Delaware  i 001-37392  i 95-4472349
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation)  File Number) Identification No.)
 
 i 1668 S. Garfield Avenue,  i 2nd Floor,  i Alhambra,  i California  i 91801
(Address of Principal Executive Offices) (Zip Code)
 
( i 626)  i 282-0288
Registrant’s Telephone Number, Including Area Code

 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
 i Common Stock i AMEHNasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 8.01
Other Events
On September 26, 2022, Apollo Medical Holdings, Inc. (“ApolloMed”) issued a press release announcing that it and its affiliated California medical corporation have entered into a definitive agreement to acquire 100% of the fully diluted capitalization of All American Medical Group (“AAMG”) and For Your Benefit, Inc. (“FYB”), as well as certain related managed care assets.

AAMG is a primary and specialty care physicians’ group focused on providing high-quality, culturally competent care to local communities in the San Francisco Bay Area. FYB is affiliated with AAMG and is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of their members under the Knox-Keene Health Care Service Plan Act of 1975.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01
Financial Statements and Exhibits

(d) Exhibits.
Exhibit No. Description
99.1
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 APOLLO MEDICAL HOLDINGS, INC.
  
By: /s/ Thomas S. Lam
 Name:
Title:
Thomas S. Lam, M.D., M.P.H.
Co-Chief Executive Officer and President



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:9/26/22None on these Dates
 List all Filings 
Top
Filing Submission 0001628280-22-025455   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 7:29:31.2am ET